A detailed history of Bank Julius Baer & Co. Ltd, Zurich transactions in Abb Vie Inc. stock. As of the latest transaction made, Bank Julius Baer & Co. Ltd, Zurich holds 42,791 shares of ABBV stock, worth $7.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
42,791
Previous 36,392 17.58%
Holding current value
$7.7 Million
Previous $6.24 Million 35.39%
% of portfolio
0.03%
Previous 0.03%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $1.05 Million - $1.28 Million
6,399 Added 17.58%
42,791 $8.45 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $1.7 Million - $1.99 Million
-10,990 Reduced 23.19%
36,392 $6.24 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $1.52 Million - $1.74 Million
9,540 Added 25.21%
47,382 $8.63 Million
Q4 2023

May 16, 2024

BUY
$137.6 - $154.97 $4.67 Million - $5.26 Million
33,941 Added 870.06%
37,842 $5.86 Million
Q4 2023

May 16, 2024

SELL
$137.6 - $154.97 $5.98 Million - $6.74 Million
-43,481 Reduced 91.77%
3,901 $604,000
Q4 2023

Feb 02, 2024

BUY
$137.6 - $154.97 $1.16 Million - $1.31 Million
8,460 Added 28.79%
37,842 $5.86 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $173,533 - $200,890
1,299 Added 4.63%
29,382 $4.38 Million
Q2 2023

Jul 24, 2023

SELL
$132.51 - $164.9 $3.72 Billion - $4.63 Billion
-28,054,775 Reduced 99.9%
28,083 $3.78 Million
Q2 2023

Jul 20, 2023

BUY
$132.51 - $164.9 $3.72 Billion - $4.63 Billion
28,049,942 Added 85216.74%
28,082,858 $3.78 Billion
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $146,200 - $168,371
1,011 Added 3.17%
32,916 $5.25 Million
Q4 2022

Jan 24, 2023

SELL
$138.31 - $165.87 $5,394 - $6,468
-39 Reduced 0.12%
31,905 $5.16 Million
Q3 2022

Nov 04, 2022

BUY
$134.21 - $153.93 $237,014 - $271,840
1,766 Added 5.85%
31,944 $4.29 Million
Q2 2022

Jul 22, 2022

BUY
$137.62 - $174.96 $238,633 - $303,380
1,734 Added 6.1%
30,178 $4.62 Million
Q1 2022

May 09, 2022

SELL
$131.98 - $163.75 $921,484 - $1.14 Million
-6,982 Reduced 19.71%
28,444 $4.61 Million
Q4 2021

Feb 15, 2022

BUY
$107.43 - $135.93 $222,380 - $281,375
2,070 Added 6.21%
35,426 $4.8 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $1.84 Million - $2.09 Million
17,323 Added 108.05%
33,356 $3.6 Million
Q2 2021

Jul 23, 2021

BUY
$105.21 - $117.21 $199,583 - $222,347
1,897 Added 13.42%
16,033 $1.81 Million
Q1 2021

May 10, 2021

BUY
$102.3 - $112.62 $1,636 - $1,801
16 Added 0.11%
14,136 $1.53 Million
Q4 2020

Feb 24, 2021

SELL
$80.49 - $108.67 $867,843 - $1.17 Million
-10,782 Reduced 43.3%
14,120 $1.51 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $1.28 Million - $1.73 Million
15,956 Added 178.36%
24,902 $1.51 Million
Q3 2020

Nov 10, 2020

BUY
$85.91 - $100.83 $35,480 - $41,642
413 Added 4.84%
8,946 $784,000
Q2 2020

Aug 12, 2020

BUY
$73.37 - $98.18 $101,030 - $135,193
1,377 Added 19.24%
8,533 $836,000
Q1 2020

May 13, 2020

BUY
$64.5 - $97.79 $461,562 - $699,785
7,156 New
7,156 $545,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Bank Julius Baer & Co. Ltd, Zurich Portfolio

Follow Bank Julius Baer & Co. Ltd, Zurich and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

News

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.